Stepan Company produces and sells specialty and intermediate chemicals primarily to manufacturers across various industries. Its operations are divided into three segments: Surfactants (approximately 50% of revenue), Polymers (around 30%), and Specialty Products (about 20%). The Surfactants segment includes ingredients for cleaning products and industrial applications, while the Polymers segment focuses on materials used in construction and consumer goods. The Specialty Products segment provides ingredients for food and pharmaceuticals. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations involve exposure to commodity price fluctuations and regulatory challenges.
—
Stepan Company produces and sells specialty and intermediate chemicals primarily to manufacturers across various industries. Its operations are divided into three segments: Surfactants (approximately 50% of revenue), Polymers (around 30%), and Specialty Products (about 20%). The Surfactants segment includes ingredients for cleaning products and industrial applications, while the Polymers segment focuses on materials used in construction and consumer goods. The Specialty Products segment provides ingredients for food and pharmaceuticals. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations involve exposure to commodity price fluctuations and regulatory challenges.
—
Daily adjusted close
Stepan Company produces and sells specialty and intermediate chemicals primarily to manufacturers across various industries. Its operations are divided into three segments: Surfactants (approximately 50% of revenue), Polymers (around 30%), and Specialty Products (about 20%). The Surfactants segment includes ingredients for cleaning products and industrial applications, while the Polymers segment focuses on materials used in construction and consumer goods. The Specialty Products segment provides ingredients for food and pharmaceuticals. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations involve exposure to commodity price fluctuations and regulatory challenges.